Skip to content

Author

Khalid Niazi

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Circulating Tumor DNA Clearance Is Associated with Response and Survival in Metastatic Urothelial Carcinoma Treated with First-Line Enfortumab Vedotin Plus Pembrolizumab

Background/Objectives: Enfortumab vedotin plus pembrolizumab (EV+pembro) is the standard first-line treatment for metastatic urothelial carcinoma (mUC), yet no validated on-treatment biomarker identifies patients deriving a durable benefit. We evaluated whether circulating tumor DNA (ctDNA) clearance is associated with...

Adam Khorasanchi, Sayan Mullick Chowdhury, E. Hong et al. · 0 citations
Open access Aug 2026

DSAI-11 AN OPTIMIZED MACHINE LEARNING MODEL FOR OVERALL SURVIVAL PREDICTION IN BRAIN METASTASIS PATIENTS USING GENOMIC MUTATION AND COPY NUMBER FEATURES

A robust machine learning framework integrating genomic mutations and copy number alterations to predict survival in BM patients demonstrates stable performance and effective risk stratification in an independent cohort, supporting its potential clinical utility for prognostic assessment and precision oncology applicat...

M. I. Ali, Z. Majeed, Peng Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.